Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells

IL-22, a signature cytokine for type 3 lymphoid cells, including T helper 17/22 (Th17/22) and type 3 innate lymphoid cells (ILC3), mediates epithelial homeostasis and protective pathogen responses in barrier tissues. Upon dysregulation, IL-22 can drive chronic inflammatory diseases, yet little is known about transcriptional elements modulating its expression. Here, we identify two enhancers, E22-1 and E22-2, with distinct capacities for regulating Il22 expression in type 3 lymphoid cells. Both enhancers are necessary for protection from Citrobacter rodentium infection and for the onset of IL-22-mediated psoriasis. E22-2 is specifically required for IL-22 expression in ILC3s, while E22-1 functions in both Th17/22 and ILC3. The ILC3 specificity of E22-2 is attributed to the presence of multiple Runx3 sites and the lack of a functional RORγt motif. We conclude that Th17/22 and ILC3 cells use distinct cis-elements to differentially regulate IL-22 expression, while orchestrating homeostatic protection and pathogen defense in barrier tissues.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-03-14
DOI
https://doi.org/10.1038/s41467-026-70636-4
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells

Katharina E. Hayer, Rebecca A. Glynn, Craig H. Bassing, Leone S. Hopkins et al.
Nature Communications
Psoriasis: Treatment and Pathogenesis
article

Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells

Katharina E. Hayer, Rebecca A. Glynn, Craig H. Bassing, Leone S. Hopkins, Eugene M. Oltz, Nicholas G Selner, Vanida A. Serna, Matthew McCullen, Ankita Saini, José Luís Fachi, Bishan Bhattarai, Marco Colonna
article en

Abstract

IL-22, a signature cytokine for type 3 lymphoid cells, including T helper 17/22 (Th17/22) and type 3 innate lymphoid cells (ILC3), mediates epithelial homeostasis and protective pathogen responses in barrier tissues. Upon dysregulation, IL-22 can drive chronic inflammatory diseases, yet little is known about transcriptional elements modulating its expression. Here, we identify two enhancers, E22-1 and E22-2, with distinct capacities for regulating Il22 expression in type 3 lymphoid cells. Both enhancers are necessary for protection from Citrobacter rodentium infection and for the onset of IL-22-mediated psoriasis. E22-2 is specifically required for IL-22 expression in ILC3s, while E22-1 functions in both Th17/22 and ILC3. The ILC3 specificity of E22-2 is attributed to the presence of multiple Runx3 sites and the lack of a functional RORγt motif. We conclude that Th17/22 and ILC3 cells use distinct cis-elements to differentially regulate IL-22 expression, while orchestrating homeostatic protection and pathogen defense in barrier tissues.

Nature Communications
Children's Hospital of Philadelphia (US), Washington University in St. Louis (US), The Ohio State University (US), University of Pennsylvania (US)
Ohio State University, Pelotonia, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 21%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells — Katharina E. Hayer, Rebecca A. Glynn, et al. · Nature Communications (2026) | TGRS Research Map | TGRS